BridgeBio Pharma Logo

BridgeBio Pharma

🇺🇸
BBIO
US10806X1028

BridgeBio Pharma is a US-based biopharmaceutical company focused on the discovery, development, and delivery of therapies for rare genetic diseases. The company aims to sustainably improve the quality of life for patients with high unmet medical needs and offer them new hope through innovative drug development.

Next Quarterly Earnings

Thursday, October 29, 2026
CW 44
After-Hours
In 63 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 1, 2026

Stock Price

Frequently asked questions

When will BridgeBio Pharma report its next quarterly earnings?

BridgeBio Pharma is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did BridgeBio Pharma last report quarterly earnings?

BridgeBio Pharma last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.78 USD.

How does BridgeBio Pharma stock react to earnings?

Across its last 3 earnings reports, BridgeBio Pharma stock moved by ±2.5% on average the following day. The largest reaction was -4.9% on 10/29/2025; 0 of 3 reactions were positive.

How often has BridgeBio Pharma beaten expectations?

BridgeBio Pharma has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the BridgeBio Pharma earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.62
Actual:
Q2 2026
Missed
Estimate:-$0.58
Actual:-$0.78
Difference:-$0.20
Q1 2026
Missed
Estimate:-$0.67
Actual:-$0.84
Difference:-$0.17
Price reaction (1 day):-0.1 %
Price reaction (7 days):+3.3 %
Q4 2025
Missed
Estimate:-$0.71
Actual:-$1.00
Difference:-$0.29
Price reaction (1 day):-2.6 %
Price reaction (7 days):-5.5 %
Q3 2025
Beat
Estimate:-$0.78
Actual:-$0.72
Difference:+$0.06
Price reaction (1 day):-4.9 %
Price reaction (7 days):-5.9 %
Q1 2025
Missed
Estimate:-$0.61
Actual:-$0.95
Difference:-$0.35

Earnings statistics

Stock reaction to earnings

±2.5%
Avg. next-day move
-4.9%
Largest move (10/29/2025)
0%
Share of positive reactions
±4.9%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-20.1%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
BridgeBio Pharma
Ticker Symbol
BBIO
ISIN
US10806X1028
Country
🇺🇸
USA
Sector